Stocks Health care INFU
NYSE · Health careInfuSystem Holdings, Inc (INFU)
InfuSystem Holdings, Inc brought in $144.4M of revenue over the twelve months to September 30, 2026, up 2.4% from a year earlier. Net income was $9.4M, a net margin of 6.5%. Operating cash flow minus capital spending left $23.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $9.1M in cash against $19.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 9, 2026.
Key facts about InfuSystem Holdings, Inc
- Net worth
- InfuSystem Holdings, Inc has a market value (market cap) of $304.3M at the latest share price, and shareholders' equity of $64.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $143.4M (+6.4% year on year), with net income of $6.6M. Over the 12 months to September 30, 2026: revenue $144.4M, net income $9.4M.
- Cash flow
- In fiscal 2025 operations brought in $24.4M of cash; after $560K of capital spending, free cash flow was $23.8M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 9, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- InfuSystem Holdings, Inc's next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What InfuSystem Holdings, Inc does
InfuSystem Holdings, Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker INFU.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $143.4M | $6.6M | $0.31 | $23.8M |
| 2024 | $134.9M | $2.3M | $0.11 | $19.4M |
| 2023 | $125.8M | $872K | $0.04 | $10.2M |
| 2022 | $109.9M | $18K | $0.00 | $16.5M |
| 2021 | $102.4M | $1.4M | $0.06 | $17.3M |
| 2020 | $97.4M | $17.3M | $0.80 | $19.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where INFU ranks in Health care
Latest SEC filings
What InfuSystem Holdings, Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026
- November 9, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 3% to $37.6M versus the same quarter last year; diluted EPS $0.15 versus $0.11.
- November 5, 2026
- November 3, 2026
- October 27, 2026
- September 17, 2026
- August 4, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 2.6% to $36.9M versus the same quarter last year; diluted EPS $0.15 versus $0.12.
- August 4, 2026
- August 4, 2026
- July 28, 2026Passive stake (5% or more) SCHEDULE 13G
What is INFU worth? A DCF from its reported cash flow
Insider trades
What the people running InfuSystem Holdings, Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 9, 2026 | Funke JerodEVP-Chief HR Officer | Exercised options | 7,157 | - |
| October 9, 2026 | Funke JerodEVP-Chief HR Officer | Shares withheld for tax | 2,101 | $28.5K |
| September 10, 2026 | Shuda ScottDirector | Other changeindirect | 20,000 | - |
| May 18, 2026 | Chupa AddamExecutive VP and CIO | Exercised options | 5,447 | - |
| May 18, 2026 | Chupa AddamExecutive VP and CIO | Shares withheld for tax | 1,994 | $17.7K |
| May 18, 2026 | Lachance CarriePresident and CEO, Director | Exercised options | 8,932 | - |
| May 18, 2026 | Lachance CarriePresident and CEO, Director | Shares withheld for tax | 3,515 | $31.3K |
| May 18, 2026 | Steele Barry GExecutive VP and CFO | Exercised options | 8,715 | - |
Who owns INFU
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Minerva Advisors LLC13G, passive with 4 related filers | 5.3% | February 17, 2026 |
Largest institutional holders
Insiders
6 insiders reported holding 828,411 shares in total, about $12.7M at the last price.
| Holder | Shares |
|---|---|
| Shuda ScottDirector | 278,383278,383 held indirectly |
| Lachance CarriePresident and CEO, Director | 266,391 |
| Steele Barry GExecutive VP and CFO | 117,767 |
| Gendron Paul AndrewDirector | 70,000 |
| Chupa AddamExecutive VP and CIO | 61,160 |
| Funke JerodEVP-Chief HR Officer | 34,710 |
Questions about INFU
What does InfuSystem Holdings, Inc do?
InfuSystem Holdings, Inc is a company in the Health care sector, listed on NYSE as INFU. Its shares trade on NYSE under the ticker INFU.
What is InfuSystem Holdings, Inc's net worth?
InfuSystem Holdings, Inc has a market value (market cap) of $304.3M at the latest share price, and shareholders' equity of $64.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is InfuSystem Holdings, Inc profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $9.4M on revenue of $144.4M, a net margin of 6.5%.
How much revenue does InfuSystem Holdings, Inc make?
Over the twelve months to September 30, 2026 InfuSystem Holdings, Inc reported revenue of $144.4M. That is 2.4% more than a year earlier.
When did InfuSystem Holdings, Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 9, 2026. It covers the period to September 30, 2026.
When is InfuSystem Holdings, Inc's next earnings report?
InfuSystem Holdings, Inc's next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare INFU with
Follow INFU
Get an email when InfuSystem Holdings, Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values InfuSystem Holdings, Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.